The Effect of Curcumin on Iron Overload in Patients with Beta-Thalassemia Intermedia.
Level 2 - randomized trial
Individual randomized controlled trial
PubMed 35254032 · doi:10.7754/Clin.Lab.2021.210629
What was done
A randomized, controlled, double-blind clinical trial evaluated the effect of curcumin supplementation on serum iron status, ferritin, and transferrin saturation in patients with beta-thalassemia intermedia. Venous blood samples (5 ml) were taken before and after the intervention to measure iron status indices. The abstract does not report the participant sample size, intervention duration, or curcumin dosage.
What was found
The curcumin group showed statistically significant decreases compared to placebo in serum iron (p < 0.001), ferritin (p = 0.002), and transferrin saturation (p < 0.001). No baseline values, post-treatment numbers, or effect sizes were reported in the abstract.
Why it matters
If validated, curcumin could serve as an adjunctive oral option to help alleviate systemic iron overload in beta-thalassemia intermedia.
Limits
The abstract omits critical methodological details including the total sample size (n), participant demographics, curcumin dose, treatment duration, and numerical baseline/endpoint measurements. Clinical outcomes, safety data, and tissue-specific iron measurements were not evaluated.
Cited by
- supports Data shows that curcumin and green tea help reduce iron levels, and sweating removes iron from the body.